Epstein-Barr virus (EBV) is a ubiquitous herpesvirus associated with a variety of malignancies including nasopharyngeal carcinoma. The EBV-encoded latent membrane protein 1 (LMP1) is considered the EBV oncogene as it is necessary for EBV-induced B-lymphocyte transformation and has been shown to transform rodent fibroblasts. LMP1 contains two signaling domains, the carboxy-terminal activating region 1 and 2 (CTAR1 and CTAR2), by which NF-jB, phosphatidylinositol 3-kinase (PI3K), mitogen-activated protein kinase, and c-Jun N-terminal kinase are activated. In this study, the role of CTAR1 and CTAR2 in LMP1-mediated transformation of rodent fibroblasts was analysed. CTAR1 was found to be necessary for rodent fibroblast transformation, whereas CTAR2 was dispensable. The activation of the PI3K pathway in Rat-1 cells by LMP1 and LMP1-CTAR1 in transformed cells resulted in phosphorylated Akt and phosphorylated glycogen synthase kinase 3b. The role of PI3K and NF-jB activation in LMP1-mediated transformation was further analysed using the chemical inhibitors LY294002 and BAY 11-7085. LY294002 inhibited CTAR1-induced focus formation and anchorage-independent growth, whereas BAY 11-7085 did not inhibit focus formation or anchorage-independent growth. Similar studies in human fibroblasts confirmed that LMP1-CTAR1 also mediates aberrant growth, phosphorylation of Akt, and decreased levels of p27. These findings indicate that LMP1-mediated rodent fibroblast transformation is dependent upon activation of PI3K and Akt and is independent of activation of NF-jB.
Introduction
Epstein-Barr virus (EBV) is a ubiquitous herpesvirus that is commonly associated with a variety of malignancies including nasopharyngeal carcinoma (NPC), post-transplant lymphoma, Hodgkin's disease, and others (Young et al., 1989; Kieff and Rickinson, 2001; Raab-Traub, 2002) . The EBV-encoded latent membrane protein 1 (LMP1) is considered the EBV oncogene as it is essential for EBV-induced B-lymphocyte transformation (Kaye et al., 1993) and transforms NIH3T3 and Rat-1 fibroblasts (Wang et al., 1985; Baichwal and Sugden, 1988; Kieff and Rickinson, 2001) . LMP1 is frequently expressed in EBV-induced malignancies including Hodgkin lymphoma and NPC (Fahraeus et al., 1988; Young et al., 1989) .
LMP1 contains 386 amino acids, with a short 23 amino-acid amino-terminal cytoplasmic tail, a transmembrane domain, and a long carboxy-terminal tail that contains two signaling domains, carboxy-terminal activating region (CTAR) 1 and 2. Through selfclustering in the membrane, LMP1 acts as a constitutively active tumor necrosis factor receptor (TNFR), mediating signaling by directly interacting with TNFRassociated factors (TRAF) through CTAR1, as well as by interacting with TNFR-associated death domain (TRADD) through CTAR2 . Signaling through the CTAR domains activates a variety of signaling pathways including NF-kB, the mitogen-activated protein kinase, c-Jun N-terminal kinase (JNK), and phosphatidylinositol 3-kinase (PI3K) (Paine et al., 1995; Eliopoulos and Young, 1998; Roberts and Cooper, 1998; Dawson et al., 2003) .
CTAR1 and CTAR2 have differing effects in the activation of various signaling pathways. CTAR2 is not required for EBV-mediated B-lymphocyte transformation, has stronger NF-kB activity in reporter assays, and can induce JNK signaling Eliopoulos and Young, 1998) . CTAR1 is necessary for B-lymphocyte transformation by EBV . CTAR1 also has unique effects in cellular gene expression as it is required for the induction of EGFR and TRAF1 expression, has recently been shown to activate PI3K (Miller et al., 1995 (Miller et al., , 1998b Devergne et al., 1998; Dawson et al., 2003) , decreases levels of p27/ KIP (Everly et al., 2004b) , and activates distinct forms of NF-kB including p50/p50 and p50/p52 dimers (Miller et al., 1998a; Thornburg et al., 2003) .
In this report, the role of CTAR1 and CTAR2 in LMP1-mediated transformation in rat and human fibroblasts as well as the role of NF-kB and PI3K signaling in LMP1-mediated transformation was analysed. CTAR1 was required for the transformation of Rat-1 cells as analysed by loss of contact inhibition as well as anchorage-independent growth while CTAR2 was dispensable. CTAR1, but not CTAR2, was required for phosphorylation of the PI3K target Akt as well as the Akt kinase target glycogen synthase kinase 3b (GSK3b). Inhibition of PI3K signaling with LY294002 blocked CTAR1-mediated focus formation and anchorage-independent growth, while the NFkB inhibitor BAY 11-7085 did not inhibit focus formation or anchorage-independent growth. In human embryo lung (HEL) fibroblasts, CTAR1 was also necessary for inducing aberrant growth, phosphorylation of Akt, and decreasing p27 levels. These data indicate that in both human and rat cells, signaling from CTAR1 induces the activity of PI3K and that this property affects growth regulation in fibroblasts.
Results

CTAR1 is required for focus formation
To determine the contribution of the two primary domains of LMP1 in cellular transformation, focus formation in Rat-1 cells was assessed by retroviral transduction with vector control (pBabe), HA-tagged full-length LMP1 (LMP1), HA-tagged LMP1 deleted for CTAR2 (1-231), and HA-tagged LMP1 deleted for CTAR1 (del187-351). Cells were analysed for focus formation (Figure 1 ) using phase-contrast (left and middle panels) and immunofluorescent microscopy for the expression of LMP1 using anti-HA antibody (right panel). Focus formation was only observed in cells transduced with LMP1 and 1-231, but not pBabe-or del187-351-transduced cells. Examination of the cells at low magnification after crystal violet staining indicated that the number of foci were relatively equivalent between LMP1 and 1-231, although foci formed by LMP1 were larger than those observed with 1-231. Focus formation was correspondingly decreased by serial dilutions of LMP1 and 1-231 (data not shown). Immunofluorescence staining for LMP1 and 1-231 revealed that expression was restricted to foci, indicating that all cells that were transduced and expressed LMP1 formed foci. However, cells transduced with del187-351 revealed a diffuse staining pattern, indicating transduction and protein expression without focus formation. Vector-transduced cells did not form foci and were negative for staining. Western blot analysis of parallel-transduced cells confirmed the expression of LMP1 and LMP1 deletion mutants (data not shown). These data indicate that CTAR1 is necessary for LMP1-mediated repression of contact inhibition, whereas CTAR2 is dispensable.
CTAR1 induces phosphorylation of the PI3K targets Akt and GSK3b
As CTAR1 and CTAR2 have been shown to activate distinct signaling events, the signaling pathways that could be involved in LMP1-induced transformation were analysed. Previous studies revealed that of the LMP1 domains, CTAR1 specifically activated PI3K (Dawson et al., 2003) . To determine if PI3K signaling was activated by CTAR1 during Rat-1 transformation, Rat-1 stable cell lines expressing LMP1, 1-231, del187-351, or vector control (pBabe) were examined for phosphorylation of the PI3K target Akt and the Akt kinase target GSK3b (Figure 2 ). Phosphorylation of Akt (Serine 473) was detected with LMP1 and at slightly lower levels with LMP1 deleted for CTAR2 (1-231) but not LMP1 deleted of CTAR1 (del187-351) or pBabe (Figure 2, 2nd panel) . The activated Akt kinase target, GSK3b, was phosphorylated and inactivated in the Rat-1 stable cell lines expressing LMP1 and 1-231, but not in pBabe or del187-351, even though LMP1 del187-351 was expressed at higher levels than LMP1 and 1-231 (Figure 2 ). The expression of del187-351 did not appear to be toxic as the cells looked healthy and continued to proliferate. These data indicate that PI3K signaling mediated by CTAR1 in Rat-1 fibroblasts is able to activate Akt and that such activation leads to the phosphorylation of the Akt target GSK3b.
PI3K signaling contributes to LMP1-induced transformation
LMP1 activates PI3K as well as distinct forms of NF-kB from both CTAR1 and CTAR2 (Miller et al., 1998a;  Figure 1 LMP1 and LMP1 CTAR1 block contact-inhibited growth in Rat-1 cells. Rat-1 fibroblasts were transduced with pBabe, LMP1, 1-231, or del187-351 retrovirus, incubated for 10-14 days, stained with crystal violet observed with phase contrast at Â 10 magnification (left panel), observed for focus formation with phase contrast at Â 50 magnification (center panel), and the same field under immunofluorescence microscopy using anti-HA antibody (right panel) Dawson et al., 2003; Thornburg et al., 2003) . To evaluate the contribution of PI3K and NF-kB signaling to LMP1-induced rodent fibroblast transformation, Rat-1 cells were transduced with pBabe, LMP1, 1-231, or del187-351, and upon reaching 100% confluency were treated with the PI3K inhibitor LY294002 (LY), the NF-kB inhibitor BAY 11-7085 (BAY 11), or dimethyl sulfoxide (DMSO) as vehicle control (Figure 3 ). In DMSO-treated cells (left column), LMP1 and 1-231 formed foci while pBabe and del187-351 did not, with 1-231 generally forming smaller foci. Treatment with LY inhibited focus formation in both LMP1 and 1-231 (middle columns), indicating that activation of the PI3K signaling pathway is required for LMP1-induced transformation. Treatment with BAY 11 (right column), on the other hand, did not inhibit focus formation induced by LMP1 or 1-231. However, BAY 11 treatment resulted in smaller foci as well as a slightly decreased number of foci in comparison to the DMSO-treated cells. These findings suggest that while LMP1-mediated NF-kB activation is not necessary for focus formation, it likely contributes to enhanced cell growth. These data indicate that activation of PI3K signaling, but not NF-kB, is required for focus formation in Rat-1 cells.
CTAR1 induces anchorage independence
To further evaluate the role of CTAR1 and CTAR2 in LMP1-mediated transformation, induction of anchorage-independent growth was assessed in soft-agar growth assays performed with cell lines stably expressing pBabe, LMP1, 1-231, and del187-351 ( Figure 4 ). As in focus formation, cells expressing LMP1 and 1-231 formed colonies in soft agar that continued to grow, whereas cells expressing del187-351 and pBabe formed small colonies that did not expand ( Figure 4a ). The efficiency of 1-231 to induce anchorage-independent growth appeared equivalent to that of LMP1 as equal number of colonies formed from equivalent numbers of cells. However, the 1-231 colonies were somewhat smaller than those in LMP1-expressing cells. These data confirm that CTAR1 signaling is required and suggest that CTAR2 enhances cell growth but is not required for blocking contact inhibition or inducing anchorage independence.
Colony formation was completely inhibited by LY treatment but not by treatment with BAY 11. To ensure that LY and BAY 11 treatment did not affect the expression of LMP1, 1-231, and del187-351, Western blot analysis was performed on the stable Rat-1 cell lines (Figure 4b ). Expression levels of LMP1, 1-231, and del187-351 were not affected by treatment with DMSO Figure 3 LY294002 but not BAY 11-7085 inhibits LMP1 and LMP1 CTAR1-induced focus formation. Rat-1 cells were transduced with pBabe, LMP1, 1-231, and del187-351, incubated for 10-14 days, stained with crystal violet, and observed for focus formation at Â 10 magnification with phase contrast. Fresh media containing DMSO, 25 mM LY294002, or 10 mM BAY 11-7085 were replaced every 48 h or LY, while BAY 11 appeared to decrease slightly del187-351 levels, but did not affect LMP1 and 1-231 levels.
To assess the effects of the chemical inhibitors on PI3K and NF-kB signaling, Rat-1 cells expressing pBabe, LMP1, 1-231, or del187-351 were analysed by immunoblotting for phosphorylated Akt, and electrophoretic mobility shift assay (EMSA) for effects on NF-kB (Figure 5a ). LY294002 treatment inhibited Akt phosphorylation (middle four lanes) compared to DMSO (leftmost four lanes). BAY 11 has been shown to inhibit the TNFa-dependent phosphorylation and subsequent degradation of the NF-kB-negative regulatory subunit IkBa (Pierce et al., 1997) . Treatment with BAY 11 (rightmost four lanes) reduced the levels of phospho-Akt in LMP1, 1-231, and del187-351 but not pBabe. This effect may reflect that Akt is also a target of NF-kB activation (Meng et al., 2002) .
To confirm that BAY 11 treatment blocked LMP1-mediated NF-kB activation, vector control and LMP1 Rat-1 stable cells were analysed by EMSA using a consensus NF-kB site (Figure 5b ). Multiple NF-kB complexes were detected in the LMP1-expressing cells that were not present in pBabe or with probe alone. The two strongest complexes, indicated by short arrows, were significantly reduced by the addition of p65 antibody, which produced two supershifted complexes, indicated by long arrows. These complexes were significantly reduced by treatment with BAY 11. These data confirm the inhibition of the PI3K and NF-kB by treatment with the inhibitors. Thus, inhibition of PI3K with LY blocked Akt phosphorylation and focus formation induced by LMP1 and LMP1-CTAR1, while inhibition of NF-kB signaling by BAY 11 did not affect focus formation induced by LMP1 and LMP1-CTAR1.
LMP1 induces aberrant growth in human fibroblasts
To determine if LMP1 signaling affects the growth of human cell lines, HEL fibroblasts were transduced with pBabe, LMP1, 1-231, or del187-351 ( Figure 6 ). Transduced cells were maintained in media with serum, stained with crystal violet, and observed for Figure 4 Anchorage-independent growth is dependent on LMP1 and LMP1 CTAR1 and is inhibited by LY294002. (a) Rat-1 stable cell lines expressing pBabe, LMP1, 1-231, and del187-351 were suspended in soft agar and incubated for 14-21 days to assay for anchorage-independent growth. Fresh media containing DMSO, 25 mM LY294002, or 10 mM BAY 11-7085 were added to the soft agar suspensions every other day for the duration of the time course. (b) Western blot analysis of Rat-1 stables expressing pBabe, LMP1, 1-231, and del187-351 using anti-HA to confirm expression when cells were treated with DMSO, LY294002, or BAY 11-7085 (Figure 6a ). Western blot analysis of the HEL extracts indicated that LMP1 and 1-231 were expressed at equivalent levels ( Figure 6 ). Interestingly, expression of del187-351 was decreased compared to that observed in Rat-1 cells. This may reflect that del187-351 remains contact inhibited, while the LMP1-and 1-231-transduced cells continue to grow. Similarly to the effects observed in Rat-1 cells, LMP1 and 1-231 activated and phosphorylated Akt to higher levels than pBabe and del187-351. Rat-1 cells expressing LMP1 and 1-231 have been shown to have decreased levels of the cyclin-dependent kinase inhibitor (cdki) p27/KIP (Everly et al., 2004b) . The expression of LMP1 and 1-231 in HEL cells also had reduced p27 protein levels compared to pBabe and del187-351 (Figure 6b ). These data also suggest that downregulation of p27 is a factor in LMP1-mediated deregulation of cellular growth. The ability of LMP1 to induce focus formation in conjunction with similar effects on signaling and cell cycle regulation in Rat-1 and HEL cells suggests that LMP1 affects both rodent and human fibroblast cell growth through similar molecular mechanisms.
Discussion
In this study, LMP1-mediated transformation of rat and human fibroblasts was analysed. The data indicate that CTAR1 is necessary for focus formation and anchorageindependent growth, whereas CTAR2 is dispensable. CTAR1 and CTAR2 were originally identified by their ability to activate NF-kB, although CTAR2 is the stronger activator in reporter assays (Rowe et al., 1994; Kaye et al., 1996; Mehl et al., 2001 ). CTAR1 interacts with several TRAF molecules including TRAFs 1, 2, 3, and 5, while CTAR2 interacts with TRADD and receptor-interacting protein and is thought to activate NF-kB primarily through TRAF2 Izumi et al., 1999; Kieff and Rickinson, 2001 ). However, CTAR1 has several unique properties and activates distinct forms of NF-kB through canonical and noncanonical pathways (Miller et al., 1997; Atkinson et al., 2003; Saito et al., 2003; Luftig et al., 2004) . Only LMP1 containing CTAR1 can induce expression of the EGFR, TRAF1, and the ID proteins, and recent studies indicate that only CTAR1 activates PI3K and inhibits expression of p27 Kaye et al., 1996; Miller et al., 1995 Miller et al., , 1997 Miller et al., , 1998a Everly et al., 2004b) . Importantly, LMP1 containing CTAR1 is required for the transformation of Blymphocytes, while CTAR2 is not necessary if the lymphocytes are cultivated on fibroblast feeder layers (Kaye et al., 1995) .
A previous study indicated that TRADD binding, mediated by CTAR2, was required for the transformation of Rat-1 cells and for inducing tumor formation in nude mice (He et al., 2000) . However, the study did not analyse the transforming potential of a CTAR1 mutant in comparison to the TRADD binding mutant. It has also been reported that Rat-1 cells that are not morphologically transformed can still form tumors in nude mice (Reynolds et al., 1987) . Similarly, the control Rat-1 cells used in this study also form tumors (data not shown).
The unique ability of CTAR1 to induce focus formation and anchorage-independent growth required the activation of PI3K. In contrast, the NF-kB inhibitor BAY 11-7085 did not inhibit focus formation or colony formation in soft agar, although the foci and colonies were generally smaller in 1-231-expressing cells than in LMP1-expressing cells, suggesting that NF-kB activation provides enhanced growth. The activation of NFkB signaling is required for the continued growth of EBV-transformed B-lymphocytes and inhibition of NF-kB signaling with a constitutively active IkB kinase, or treatment with BAY 11, induces massive apoptotic death (Luftig et al., 2004) . However, EBV transformation of B-lymphocytes reflects immortalization and transformation of primary cells. In contrast, rodent fibroblast transformation identifies altered morphology and growth properties in an established cell line. These findings indicate that activation of PI3K is required for the morphologic changes and deregulated growth of fibroblasts including loss of contact inhibition and anchorage dependence, while activation of NF-kB can The requirement of PI3K-Akt signaling for EBV transformation of B-lymphocytes is as yet unknown. However, the data presented in this study indicate that activation of PI3K is an important aspect of CTAR1 signaling and is likely also required for lymphocyte transformation. In this study, the transformation properties of LMP1 were also demonstrated in HEL fibroblasts. Similarly to Rat-1 cells, in the HEL cells fulllength LMP1 and CTAR1 but not CTAR2 induced focus formation as well as phosphorylation of Akt. Furthermore, CTAR1 but not CTAR2 decreased the levels of the cdki p27/KIP. The ability of LMP1 to decrease p27 in HEL cells as well as previous data in Rat-1 cells indicating decreased p27 levels suggests that p27 downregulation contributes to LMP1-induced transformation (Everly et al., 2004b) .
LMP1 has long been known to associate with vimentin and the cytoskeleton (Liebowitz and . This property has been mapped to the CTAR1 domain and mutated forms of CTAR1 that do not interact with the TRAF molecules do not associate with the cytoskeleton (Higuchi et al., 2001) . PI3K activation by CTAR1 has also been shown to induce actin stress fiber formation (Puls et al., 1999; Dawson et al., 2003) . The requirement for CTAR1, the activation of PI3K, and the link between CTAR1 and the cytoskeleton suggests that the morphologic transformation of rodent fibroblasts induced by CTAR1 is induced by the activation of PI3K and by LMP1-induced interactions between TRAFs and the cytoskeleton.
The PI3K target Akt is known to phosphorylate and inactivate GSK3b (Cross et al., 1995) ; however, the role of LMP1-mediated GSK3b inactivation remains to be elucidated. The EBV latent membrane protein 2A also activates the PI3K-Akt signaling pathway resulting in the inactivation of GSK3b and subsequent activation of the proto-oncogene b-catenin in epithelial cells (Morrison et al., 2003) . b-catenin acts by interacting with members of the T-cell factor/lymphoid enhancer factor family of transcription factors (Shtutman et al., 1999) . Interestingly, a comparison of EBV-positive and EBVnegative lymphoid cell lines revealed higher levels of cytoplasmic, but not nuclear b-catenin (Everly et al., 2004a) . The presence of high levels of cytoplasmic b-catenin but not nuclear levels indicated that in EBV-transformed lymphocytes, the effects of LMP1 and LMP2 activation on PI3K and phosphorylation of GSK3b resulted in b-catenin accumulation but did not affect b-catenin localization. The targets of Akt or GSK3b may be distinct in lymphoid and epithelial cells. Potential differences in the targets of activated Akt in lymphocytes and epithelial cells have also been observed in EBV-associated tumors. Activated Akt was detected in NPC and in the Reed-Steinberg cells of Hodgkin's disease; however, nuclear b-catenin was only detected in the malignant epithelial cells of NPC (Morrison et al., 2004) . It is also possible that LMP1 and LMP2 affect distinct pools of cellular GSK3b. GSK3b can be phosphorylated by different kinases in various intracellular locations and it has been shown that GSK3b phosphorylation induced by wnt signaling but not insulin signaling results in activated b-catenin (Ding et al., 2000) . Thus, LMP1 and LMP2A may be affecting phosphorylation of different pools of GSK3b that results in the activation of different signaling pathways in different cell backgrounds.
The induction of focus formation, phosphorylation of Akt, and decreased expression of the cdki p27/KIP by LMP1 in HEL cells reveals new properties of CTAR1. The downregulation of p27 in Rat-1 cells and HEL cells by CTAR1 suggests that deregulation of the cell cycle is a component of LMP1-mediated growth transformation (Everly et al., 2004b) . Importantly, these findings indicate that the ability of LMP1 to transform rodent fibroblasts requires some but not all of the biochemical properties of LMP1. The full effects of LMP1 including activation of NF-kB and perhaps other pathways are likely required for the transformation of primary lymphocytes and the oncogenic properties of LMP1 in EBV-associated tumors.
Materials and methods
Retrovirus production and transduction
Plasmid constructs expressing HA-tagged full-length LMP1, LMP(1-231), LMP(del187-351), pBabe, pVSVG, and pGag/ Pol and recombinant retrovirus production was described previously (Everly et al., 2004b) . Briefly, subconfluent 293Ts were triple transfected using FuGENE 6 transfection reagent (Roche) according to manufacturer's directions with 5 mg pBabe (vector), pBabe-HA-LMP1, pBabe-HA-1-231, or pBabe-HA-del187-351, and 5 mg pVSV-G and 5 mg pGag/Pol expressing plasmids. Following overnight incubation at 371C, media were replaced with fresh media and cells were incubated at 331C. The following day, cell supernatant was centrifuged at 1000 g for 5 min to remove cell debris. Rat-1 or HEL cells were then transduced with clarified supernatant with 4 mg/ml polybrene overnight.
Cell culture and stable cell lines
Rat-1 fibroblasts and human embryo kidney 293Ts were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with heat-inactivated 10% fetal bovine serum (FBS) and antibiotic/antimycotic (GIBCO). HEL 299 cells were maintained in minimum essential medium alpha and the additives mentioned for DMEM as well as nonessential amino acids. Rat-1 stable cell lines expressing full-length LMP1, LMP(1-231), LMP(del187-351), or vector control (pBabe) were established by transduction with recombinant retrovirus followed by selection with 5 mg/ml puromycin (Sigma).
Western blotting and densitometry analysis
Cell lines were grown to confluency and harvested as described previously (Everly et al., 2004b) . Briefly, postharvesting, cells were washed with ice-cold phosphate-buffered saline (PBS, GIBCO), centrifuged at 1000 g, lysed with RIPA buffer (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% NP40, 0.1% SDS, 0.1% deoxycholate, protease and phosphatase inhibitors). Lysates were clarified by centrifugation and protein concentration was determined using Bio-Rad DC protein assay system. Lysates were boiled in SDS sample buffer and 25 mg of protein were separated by SDS-PAGE and transferred to Optitran s (Schleicher and Schuell) for Western blot analysis. Primary antibodies used include b-actin (Santa Cruz), CS1-4 (Dako), HA-probe (Santa Cruz); phospho-Akt (Ser 473), total Akt, phospho-GSK3b (Ser 9), p27 (Calbiochem); and total GSK3 (Upstate Biotechnology). Bound proteins were detected with horseradish peroxidase-conjugated secondary antibodies (Amersham Parmacia and Dako) and Pierce Supersignal West Pico System followed by exposure to film.
Immunofluorescent labeling and phase-contrast microscopy
Rat-1 cells stably expressing LMP1, 1-231, del187-351, or pBabe were seeded into six-well plates and maintained for 10-14 days, changing the media every other day, under puromycin selection for foci formation. Wells were then washed once with PBS, fixed with methanol for 5 min at room temperature, and washed three times with PBS. Cells were blocked for 20 min with PBS containing 20% normal goat serum (NGS), incubated with primary antibody in PBS-20% NGS for 1 h, washed three times with PBS, incubated with rhodamine-conjugated secondary (Jackson Laboratories) in PBS-20% NGS for 1 h, and washed three times with PBS. Stained cells were examined with phase-contrast and fluorescence microscopy.
Focus formation and soft agars
Subconfluent Rat-1 or HEL cells were transduced with recombinant retrovirus in six-well plates overnight. Cells were then maintained by changing the media every other day for 10-14 days. To assay focus formation in the presence of chemical inhibitors, stable cell lines were seeded in six-well plates. Upon cells reaching confluency, and every other day thereafter, fresh media containing 25 mM LY294002 (Calbiochem), 10 mM BAY 11-7085 (Calbiochem) or vehicle control (DMSO, Sigma) used at 1 : 1000 was added to the cells. Cells were then stained with 1% crystal violet in 50% ethanol and imaged with a stereomicroscope. Soft agars were carried out as described previously (Scholle et al., 2000) . Briefly, Bacto agar medium (1 ml 5% Bacto agar and 9 ml DMEM with 10% FBS and antibiotic/antimycotic) was poured into a 12-well plate and allowed to solidify. A total of 1.0 Â 10 4 cells/well were resuspended in Bacto agar medium, overlaid the initial layer of Bacto agar medium, and allowed to solidify. The media containing 1 : 1000 DMSO, 25 mM LY294002, or 10 mM BAY 11-7085 were changed every other day. Cells were then imaged by phase-contrast or a dissecting microscope.
Electrophoretic mobility shift assay
Nuclear fractionations and EMSAs were performed as described previously (Thornburg et al., 2003) . Rat-1 cells stably transduced with pBabe or LMP1 retrovirus were treated with Bay 11-7085 (10 mM) or vehicle control (DMSO) for 24 h and fractionated. DNA-protein complexes were formed by mixing 10 mg of nuclear extract with 100 000 counts of the UV21 double-stranded oligonucleotide probe (CAGGGCTG GGGATTCCCCATCTCCCACAGTTTCACTTC), which is based on the H-2K b gene containing a consensus NF-kB binding site (underlined) labeled with [a- 32 P]dCTP. After allowing the complexes to form for 15 min at room temperature, DNA-protein complexes were resolved on 5% PAGE and imaged using a PhosphorImager (Molecular Dynamics). Probe alone and positive control, recombinant p50 (Promega), were included and p65 containing complexes were determined by supershifting with anti-p65 antibody (Rockland).
